|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2013.01) | ||
| G01N 33/57492 | (2013.01) | ||
| A61K 47/6809 | (2017.08) | ||
| A61K 47/6849 | (2017.08) | ||
| A61K 47/6869 | (2017.08) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3636279 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19192583.3 |
| Date of filing the European patent application | 2012-03-30 | |
| (97) | Date of publication of the European application | 2020-04-15 |
| (45) | Date of publication and mention of the grant of the patent | 2023-09-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161471007 P | 2011-04-01 | US |
| (72) |
Carrigan, Christina , US
Whiteman, Kathleen R. , US
Payne, Gillian , US
Ladd, Sharron , US
|
| (73) |
ImmunoGen, Inc. ,
830 Winter Street, Waltham, MA 02451,
US
|
| (54) | METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY |
| METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY |